Researchers have developed human cardiac organoids in order to model myocardial infarction and drug cardiotoxicity. A team of biomedical researchers from the Medical University of South Carolina and Clemson University (both SC, USA) have succeeded in developing human cardiac organoids, less than 1mm in diameter, that can replicate the physiological conditions that occur during a heart attack. “We were essentially able to take that 3D complex nature of a heart attack and then downsize it into a microtissue model,” remarked Dylan Richards (Clemson University), a co-author on the study which was published recently in Nature Biomedical Engineering. In the USA,...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!